X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (71843) 71843
Book Review (10672) 10672
Newsletter (8857) 8857
Publication (3944) 3944
Book Chapter (537) 537
Conference Proceeding (469) 469
Newspaper Article (245) 245
Dissertation (191) 191
Magazine Article (189) 189
Book / eBook (94) 94
Web Resource (39) 39
Trade Publication Article (21) 21
Paper (17) 17
Journal / eJournal (14) 14
Reference (11) 11
Government Document (8) 8
Transcript (3) 3
Data Set (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (52112) 52112
humans (43285) 43285
male (29278) 29278
female (24115) 24115
nephropathy (20371) 20371
middle aged (17669) 17669
urology & nephrology (16596) 16596
diabetic nephropathies (16156) 16156
adult (15733) 15733
animals (14445) 14445
diabetes (11837) 11837
aged (10897) 10897
diabetic nephropathy (10625) 10625
research (9069) 9069
risk factors (8476) 8476
rats (7756) 7756
kidney diseases (7267) 7267
endocrinology & metabolism (6844) 6844
disease (6115) 6115
hypertension (5953) 5953
transplantation (5885) 5885
proteinuria (5735) 5735
iga nephropathy (5475) 5475
mice (5285) 5285
diabetes mellitus (5284) 5284
kidney - pathology (5136) 5136
adolescent (5009) 5009
nephrology (4896) 4896
kidneys (4871) 4871
diabetic-nephropathy (4743) 4743
analysis (4700) 4700
kidney (4679) 4679
diabetic nephropathies - physiopathology (4565) 4565
expression (4562) 4562
medicine, general & internal (4558) 4558
oxidative stress (4494) 4494
glomerular filtration rate (4424) 4424
type 2 diabetes (4327) 4327
mellitus (4196) 4196
abridged index medicus (4082) 4082
care and treatment (3910) 3910
progression (3822) 3822
diabetes mellitus, type 2 - complications (3820) 3820
medical research (3817) 3817
time factors (3747) 3747
disease progression (3698) 3698
reports (3684) 3684
kidney transplantation (3676) 3676
treatment outcome (3585) 3585
microalbuminuria (3535) 3535
diabetic nephropathies - metabolism (3512) 3512
albuminuria (3507) 3507
mortality (3471) 3471
diabetic nephropathies - pathology (3468) 3468
child (3460) 3460
risk (3454) 3454
medicine, experimental (3397) 3397
development and progression (3395) 3395
glomerulonephritis (3370) 3370
chronic kidney failure (3357) 3357
health aspects (3304) 3304
prognosis (3297) 3297
retrospective studies (3274) 3274
blood pressure (3263) 3263
prevalence (3248) 3248
biopsy (3226) 3226
diabetic nephropathies - drug therapy (3224) 3224
fibrosis (3197) 3197
inflammation (3173) 3173
diabetic nephropathies - etiology (3143) 3143
creatinine - blood (3113) 3113
medicine & public health (3105) 3105
pharmacology & pharmacy (3105) 3105
follow-up studies (3089) 3089
medicine, research & experimental (3047) 3047
complications (2972) 2972
immunology (2969) 2969
diabetic nephropathies - complications (2911) 2911
glucose (2907) 2907
rodents (2873) 2873
surgery (2871) 2871
kidney - metabolism (2851) 2851
kidney - drug effects (2830) 2830
proteins (2822) 2822
chronic kidney disease (2687) 2687
diabetic nephropathies - therapy (2641) 2641
peripheral vascular disease (2628) 2628
diabetic nephropathies - blood (2567) 2567
chronic kidney-disease (2563) 2563
blood-pressure (2559) 2559
kidney - physiopathology (2545) 2545
prospective studies (2503) 2503
diabetes mellitus, type 1 - complications (2477) 2477
diabetics (2476) 2476
prevention (2473) 2473
nephrotic syndrome (2440) 2440
diabetic nephropathies - prevention & control (2394) 2394
apoptosis (2377) 2377
diagnosis (2368) 2368
disease models, animal (2360) 2360
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Online Resources - Online (25) 25
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
St. Michael's Hospital - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Gerstein Science - Bindery (2) 2
Gerstein Science - Periodical Stacks (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - General (2) 2
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Theses (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Grace (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (75407) 75407
German (1146) 1146
Japanese (945) 945
French (905) 905
Spanish (842) 842
Russian (545) 545
Chinese (519) 519
Korean (447) 447
Polish (341) 341
Czech (184) 184
Italian (159) 159
Portuguese (159) 159
Hungarian (90) 90
Turkish (60) 60
Slovak (54) 54
Bulgarian (49) 49
Serbian (48) 48
Croatian (46) 46
Finnish (24) 24
Danish (21) 21
Persian (20) 20
Hebrew (18) 18
Dutch (17) 17
Swedish (17) 17
Romanian (12) 12
Ukrainian (12) 12
Bosnian (6) 6
Norwegian (4) 4
Slovenian (4) 4
Arabic (2) 2
Greek (2) 2
Catalan (1) 1
Icelandic (1) 1
Indonesian (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 03/2012, Volume 81, Issue 6, pp. 559 - 567
Endemic (Balkan) nephropathy is a chronic tubulointerstitial disease frequently accompanied by urothelial cell carcinomas of the upper urinary tract. This... 
upper urinary tract cancer | endemic nephropathy | DNA adducts | Aristolochia | nephrotoxicity | aristolochic acid | ETIOLOGY | UPPER URINARY-TRACT | CHINESE HERBS NEPHROPATHY | OCHRATOXIN-A | GENOTOXICITY | BALKAN ENDEMIC NEPHROPATHY | DISEASE | CANCER-RISK | UROLOGY & NEPHROLOGY | KIDNEY | RISK-ASSESSMENT | Urologic Neoplasms - epidemiology | Humans | Middle Aged | Balkan Nephropathy - chemically induced | Male | DNA Adducts - analysis | DNA Mutational Analysis | Croatia - epidemiology | Aged, 80 and over | Balkan Nephropathy - genetics | Genetic Predisposition to Disease | Risk Assessment | Balkan Nephropathy - metabolism | Risk Factors | Biomarkers - analysis | Environmental Monitoring - methods | Urologic Neoplasms - chemically induced | Environmental Exposure | Bosnia and Herzegovina - epidemiology | Aristolochic Acids - adverse effects | Diet | Epidemiological Monitoring | Molecular Epidemiology | Carcinoma - genetics | Mutation | Carcinogens, Environmental - metabolism | Balkan Nephropathy - epidemiology | Kidney Cortex - drug effects | Residence Characteristics | Urologic Neoplasms - diagnosis | Case-Control Studies | Tumor Suppressor Protein p53 - genetics | Urologic Neoplasms - genetics | Biotransformation | Carcinoma - epidemiology | Mass Spectrometry | Carcinogens, Environmental - adverse effects | Adult | Female | Urologic Neoplasms - metabolism | Carcinoma - chemically induced | Carcinoma - diagnosis | Kidney Cortex - pathology | Aristolochic Acids - metabolism | Kidney Cortex - chemistry | Aged | Balkan Nephropathy - diagnosis | Carcinoma - metabolism | Serbia - epidemiology | Urine | renal cortex | Carcinoma | biomarkers | Mass spectroscopy | Aristolochic acid | Urinary tract | urothelium | Kidney | p53 protein | Diets | Carcinogens | Nephropathy | urothelial carcinoma | DNA | Metabolic activation | genomics | Bioindicators | Mass spectrometry | Adducts | Tumors | Index Medicus
Journal Article
Journal Article
1999, Contributions to nephrology, ISBN 3805568339, Volume 126., ix, 115
It is clear that IgA nephropathy is one of the most common types of chronic glomerulonephritis in the world. It is also recognized that this disease is the... 
IgA glomerulonephritis
Book
2009, ISBN 9789812835864, xx, 419
Book
Scientific reports, ISSN 2045-2322, 05/2019, Volume 9, Issue 1, pp. 7185 - 2
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper. 
Nephropathy
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 23, pp. 2453 - 2453
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 08/2018, Volume 36, Issue 23, pp. 2454 - 2454
Journal Article
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 12/2012, Volume 265, Issue 3, pp. 360 - 367
Aristolochic acid causes a specific nephropathy (AAN), Balkan endemic nephropathy, and urothelial malignancies. Using Western blotting suitable to determine... 
Mouse models | Metabolic activation | Protein expression | NAD(P):quinone oxidoreductase | DNA adducts | Balkan endemic nephropathy | Aristolochic acid nephropathy | Aristolochic acid nephropathy$Balkan endemic nephropathy$NAD(P):quinone oxidoreductase$Protein expression$Metabolic activation$DNA adducts$Mouse models | UROTHELIAL CANCER | NAD(P)H-QUINONE OXIDOREDUCTASE-1 | ARISTOLACTAM-DNA ADDUCTS | METABOLIC-ACTIVATION | CYTOCHROMES P450 1A1 | CHINESE HERBS NEPHROPATHY | ARYL-HYDROCARBON RECEPTOR | GENE-EXPRESSION | ENVIRONMENTAL CARCINOGEN | PHARMACOLOGY & PHARMACY | TOXICOLOGY | Cytochrome P-450 CYP1A1 - genetics | Liver - enzymology | Humans | DNA Adducts - metabolism | Cytosol - enzymology | Aristolochic Acids - pharmacokinetics | Liver - drug effects | Cytochrome P-450 CYP1A2 - genetics | Cytochrome P-450 CYP1A2 - deficiency | Female | Cytochrome P-450 CYP1A1 - deficiency | Aristolochic Acids - toxicity | Cell Line | Balkan Nephropathy - genetics | Balkan Nephropathy - metabolism | Liver - metabolism | Mice, Inbred C57BL | Mice, Transgenic | Cytochrome P-450 CYP1A1 - metabolism | Cytochrome P-450 CYP1A2 - metabolism | Blotting, Western | Mice, Knockout | NAD(P)H Dehydrogenase (Quinone) - biosynthesis | Animals | Balkan Nephropathy - enzymology | NAD(P)H Dehydrogenase (Quinone) - metabolism | Cytosol - metabolism | Mice | Index Medicus | Enzymes | Cytochrome P450 | Liver | Lung | Genotoxicity | Transgenic mice | Aristolochic acid | Malignancy | CYP1A2 protein | Kidney | Western blotting | NAD(P)H:quinone oxidoreductase | Carcinogens | Nephropathy | DNA | NAD(P)H dehydrogenase (quinone) | Adducts | SULFATES | HYDROCARBONS | CARCINOGENS | METABOLIC ACTIVATION | THIN-LAYER CHROMATOGRAPHY | BENZOQUINONES | 60 APPLIED LIFE SCIENCES | ECR HEATING | DNA ADDUCTS | KIDNEYS | NAD | OXYGEN | URINARY TRACT | ENZYMES | LIVER | CARCINOMAS | RECEPTORS | TRANSGENIC MICE
Journal Article
2014, ISBN 9781493907939
Web Resource
Journal of Cellular Physiology, ISSN 0021-9541, 10/2017, Volume 232, Issue 10, pp. 2776 - 2787
Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of... 
dynamin‐related protein 1 | polydatin | diabetic nephropathy | dynamin-related protein 1 | APOPTOSIS | OXIDATIVE STRESS | ACTIVATION | PHYSIOLOGY | DIABETIC-NEPHROPATHY | DEFICIENCY | CELL-DEATH | CELL BIOLOGY | PATHOGENESIS | MICE | FISSION | DYSFUNCTION | Dynamins - metabolism | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Diabetic Nephropathies - etiology | Diabetic Nephropathies - drug therapy | Diabetes Mellitus, Type 2 - metabolism | Stilbenes - pharmacology | Transfection | RNA Interference | Diabetes Mellitus, Type 2 - complications | Cytoprotection | Disease Models, Animal | Cell Line | Diabetic Nephropathies - pathology | Glucosides - pharmacology | Podocytes - metabolism | Diabetic Nephropathies - metabolism | Down-Regulation | Mice, Inbred C57BL | Dynamins - genetics | Mitochondria - metabolism | Mitochondria - drug effects | Mitochondria - pathology | Podocytes - pathology | Animals | Mitochondrial Dynamics - drug effects | Podocytes - drug effects | Signal Transduction - drug effects | Diabetes Mellitus, Type 2 - pathology | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hyperglycemia | Analysis | Diabetic nephropathies | Retarding | Mitochondria | Renal function | Nephropathy | Diabetes mellitus | Rodents | Resveratrol | Dynamin | Apoptosis | Fitness | Index Medicus | Original | Original s
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 839 - 848
In a randomized, controlled trial, liraglutide (a glucagon-like peptide 1 receptor agonist) or placebo was added to usual care in patients with type 2... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR OUTCOMES | ALBUMINURIA | INTENSIVE GLUCOSE CONTROL | KIDNEY-FUNCTION | DISEASE | RISK | DEATH | NEPHROPATHY | Hypoglycemic Agents - therapeutic use | Glomerular Filtration Rate | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Albuminuria - prevention & control | Acute Kidney Injury - prevention & control | Diabetic Nephropathies - mortality | Kidney Failure, Chronic - prevention & control | Glucagon-Like Peptide 1 - agonists | Liraglutide - adverse effects | Liraglutide - therapeutic use | Intention to Treat Analysis | Creatinine - blood | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Care and treatment | Usage | Analysis | Diabetic nephropathies | Outcome and process assessment (Health Care) | Research | Liraglutide | Myocardial infarction | Creatinine | Cerebral infarction | End-stage renal disease | Stroke | Glucagon | Diabetes mellitus | Patients | Risk factors | Clinical outcomes | Glomerular filtration rate | Death | Diabetes | Kidney diseases | Cardiovascular diseases | Drug therapy | Glucagon-like peptide 1 | Long-term effects | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article